Lymphoproliferative responses after infection with human parvovirus B19

Journal of Virology

Volumn 70, Issue 10, 1996, Pages 7327-7330

  Von Poblotzki, Andreas ^a,b   Gerdes, Christian ^a   Reischl, Udo ^a   Wolf, Hans ^a   Modrow, Susanne ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b SmithKline Beecham Pharma GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CELLULAR IMMUNITY; HUMORAL IMMUNITY; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; NONHUMAN; PARVOVIRUS; PRIORITY JOURNAL;

EID: 0029815038     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.10.7327-7330.1996     Document Type: Article

References (21)

1. Anderson, L. J. 1990. Human parvoviruses. J. Infect. Dis. 161:603-608.
2. Anderson, M. J., S. E. Jones, S. P. Fisher-Hoch, E. Lewis, S. M. Hall, C. L. R. Bartlett, B. J. Cohen, P. P. Mortimer, and M. S. Pereira. 1983. Human parvovirus: the cause of erythema infectiosum (fifth disease)? Lancet i:1378.
3. Bogedain, C., H. Wolf, S. Modrow, G. Stuber, and W. Jilg. 1995. Specific cytotoxic T lymphocytes recognize the immediate-early transactivator Zta of Epstein-Barr virus. J. Virol. 69:4872-4879.
4. Cohen, B. J., M. M. Buckley, J. P. Clewley, V. E. Jones, A. H. Puttick, and R. K. Jacoby. 1986. Human parvovirus infection in early rheumatoid and inflammatory arthritis. Ann. Rheum. Dis. 45:832-838.
5. Frickhofen, N., J. L. Abkowitz, M. Safford, J. M. Berry, J. Antunez de Mayolo, A. Astrow, R. Cohen, I. Halperin, L. King, and D. Mintzer. 1990. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann. Intern. Med. 113:926-933.
6. Frickhofen, N., and N. S. Young. 1989. Persistent parvovirus B19 infections in humans. Microb. Pathog. 7:319-327.
7. Graham, S., E. C. Y. Wang, O. Jenkins, and L. K. Borysiewicz. 1993. Analysis of the human T-cell response to picornaviruses: identification of T-cell epitopes close to B-cell epitopes in poliovirus. J. Virol. 67:1627-1637.
8. Kurtzman, G., N. Frickhofen, J. Kimball, D. W. Jenkins, A. W. Nienhuis, and N. S. Young. 1989. Pure red-cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. N. Engl. J. Med. 321:519-523.
9. Kurtzman, G. J., B. J. Cohen, A. M. Field, R. Oseas, R. M. Blaese, and N. S. Young. 1989. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J. Clin. Invest. 84:1114-1123.
10. Lovett, A. E., M. McCarthy, and J. S. Wolinsky. 1993. Mapping cell-mediated immunodominant domains of the rubella virus structural proteins using recombinant proteins and synthetic peptides. J. Gen. Virol. 74:445-452.
11. McCarthy, M., A. Lovett, R. H. Kerman, A. Overstreet, and J. S. Wolinsky. 1993. Immunodominant T-cell epitopes of rubella virus structural proteins defined by synthetic peptides. J. Virol. 67:673-681.
12. Naides, S. J., L. L. Scharosch, F. Foto, and E. J. Howard. 1990. Rheumatologic manifestations of human parvovirus B19 infection in adults. Initial two-year clinical experience. Arthritis Rheum. 33:1297-1309.
13. Pattison, J. R., S. E. Jones, and J. Hodgson. 1981. Parvovirus infections and hypoplastic crises in sickle cell anaemia. Lancet i:664.
14. Pont, J., E. Puchhammer Stockl, A Chott, T. Popow Kraupp, H. Kienzer, G. Postner, and N. Honetz. 1992. Recurrent granulocytic aplasia as clinical presentation of a persistent parvovirus B19 infection. Br. J. Haematol. 80: 160-165.
15. Reid, D. M., T. M. Reid, T. Brown, J. A. Rennie, and C. J. Eastmond. 1985. Human parvovirus-associated arthritis: a clinical and laboratory description. Lancet i:422-425.
16. Schwarz, T. F., M. Roggendorf, B. Hottenträger, F. Deinhardt, G. Enders, K.-P. H. Gloning, T. Schramm, and M. Hausmann. 1988. Human parvovirus infection in pregnancy. Lancet ii:566-567.
17. Serjeant, G. R., B. E. Serjeant, P. W. Thomas, M. J. Anderson, G. Patou, and J. R. Pattison, 1993. Human parvovirus infection in homozygous sickle cell disease. Lancet 341:1237-1240.
18. Simons, J., M. Kutubuddin, and M. Chow. 1993. Characterization of poliovirus-specific T lymphocytes in the peripheral blood of Sabin-vaccinated humans. J. Virol. 67:1262-1268.
19. von Poblotzki, A., A. Gigler, B. Lang, H. Wolf, and S. Modrow. 1995. Antibodies to parvovirus B19 NS-1 protein in infected individuals. J. Gen. Virol. 76:519-527.
20. von Poblotzki, A., A. Hemauer, A. Gigler, E. Puchhammer-Stöckl, F.-X. Heinz, J. Pont, K. Laczika, H. Wolf, and S. Modrow. 1995. Antibodies to the non-structural protein of parvovirus B19 in persistently infected patients: implications for pathogenesis. J. Infect. Dis. 172:1356-1359.
21. White, D. G., A. D. Woolf, P. P. Mortimer, B. J. Cohen, D. R. Blake, and P. A. Bacon. 1985. Human parvovirus arthropathy. Lancet i:419-421.